https://orcid.org/0000-0002-7246-6040
Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yan Shen Kee, Chee Kuan Wong, Muhammad Anis Abdul Aziz, Mohd Idzwan Zakaria, Fatimah Mohd Shaarif, Kee Seong Ng, Chong Kin Liam, Yong Kek Pang & Ee Ming Khoo. (2023) 30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2623-2631.
Read now
Read now
Xiaoyi Feng, Huaye Xiao, Yishan Duan, Qinxue Li & Xuemei Ou. (2023) Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1219-1230.
Read now
Read now
Articles from other publishers (14)
Chou-Chin Lan, Kuan-Hung Yeh, I-Shiang Tzeng, Po-Chun Hsieh, Mei-Chen Yang, Chih-Wei Wu, Wen-Lin Su & Yao-Kuang Wu. (2023) Evaluation of the relationship of tricuspid regurgitation peak gradient/tricuspid annulus plane systolic excursion to exercise capacity, cardiac index, and ventilatory function during exercise in patients with COPD. Heart & Lung 62, pages 22-27.
Crossref
Crossref
Hongtao Cheng, Jieyao Li, Fangxin Wei, Xin Yang, Shiqi Yuan, Xiaxuan Huang, Fuling Zhou & Jun Lyu. (2023) A risk nomogram for predicting prolonged intensive care unit stays in patients with chronic obstructive pulmonary disease. Frontiers in Medicine 10.
Crossref
Crossref
Sanjay SethiSwetha R PalliLindsay G S BengtsonErin K BuysmanBrendan ClarkAndrew SargentAsif ShaikhGary T Ferguson. (2023) Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. Journal of Managed Care & Specialty Pharmacy 29:7, pages 791-806.
Crossref
Crossref
Peihua Zhang, Niphawan Samartkit & Khemaradee Masingboon. (2023) Factors associated with health-related quality of life among employed individuals with chronic obstructive pulmonary disease: A correlational study in China. Belitung Nursing Journal 9:3, pages 271-279.
Crossref
Crossref
Chou-Chin Lan, Po-Chun Hsieh, I-Shiang Tzeng, Mei-Chen Yang, Chih-Wei Wu, Wen-Lin Su & Yao-Kuang Wu. (2023) Impact of bisoprolol and amlodipine on cardiopulmonary responses and symptoms during exercise in patients with chronic obstructive pulmonary disease. PLOS ONE 18:6, pages e0286302.
Crossref
Crossref
Chee-Shee Chai, Diana-Leh-Ching Ng, Sumastika Bt Mos, Muhammad Amin B Ibrahim, Seng-Beng Tan, Yong-Kek Pang & Chong-Kin Liam. (2023) COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV1 – a post-hoc analysis of pooled data. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Jacob R. Weiss, Ryan Serdenes, Uchechukwu Madtha, Huaqing Zhao, Victor Kim, Jahaira Lopez-Pastrana, Michelle N. Eakin, Jacqueline O'Toole, Christopher B. Cooper, Prescott Woodruff, Richard E. Kanner, Jerry A. Krishnan, Anand S. Iyer, David Couper & Mary F. Morrison. (2023) Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort. Journal of the Academy of Consultation-Liaison Psychiatry 64:1, pages 45-57.
Crossref
Crossref
Joseph Emil Amegadzie, John-Michael Gamble, Jamie Farrell & Zhiwei Gao. (2022) Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap. Respiratory Research 23:1.
Crossref
Crossref
Linah Saraireh, Mhd Saeed Sharif & Muna Alsallal. (2022) An Effective Random Generalised Linear Model to Predict COPD. An Effective Random Generalised Linear Model to Predict COPD.
Christine Råheim Borge, Marie Hamilton Larsen, Richard H Osborne, Eivind Engebretsen, Marit Helen Andersen, Ingrid Asbjørnsen Holter & Astrid K Wahl. (2022) How to co-design a health literacy-informed intervention based on a needs assessment study in chronic obstructive pulmonary disease. BMJ Open 12:10, pages e063022.
Crossref
Crossref
Kh. S. Razhabov & I. V. Liverko. (2022) Prognosis of the Course of Chronic Obstructive Pulmonary Disease with Obstructive Sleep Apnea-Hypopnea Syndrome. Tuberculosis and Lung Diseases 100:7, pages 22-27.
Crossref
Crossref
Rui Lv, Mengyao Xie, Huaqian Jin, Pingping Shu, Mingli Ouyang, Yanmao Wang, Dan Yao, Lehe Yang, Xiaoying Huang & Yiran Wang. (2022) A Preliminary Study on the Relationship Between High-Resolution Computed Tomography and Pulmonary Function in People at Risk of Developing Chronic Obstructive Pulmonary Disease. Frontiers in Medicine 9.
Crossref
Crossref
Eanes Delgado Barros Pereira1 & Antonio George de Matos Cavalcante1. (2022) Prescription is not enough: the importance of adherence to pharmacological treatment of COPD. Jornal Brasileiro de Pneumologia, pages e20220058.
Crossref
Crossref
Massimiliano Polastri, Antonio Loforte, Andrea Dell'Amore & Justyna Swol. (2021) Physiotherapy and artificial lungs: looking to the future. International Journal of Therapy and Rehabilitation 28:8, pages 1-4.
Crossref
Crossref